© 2020 MJH Life Sciences and HCPLive. All rights reserved.
June 19, 2020
June 17, 2020
The approval is based on the phase 3 PREVENT trial, presented at the European E-Congress of Rheumatology 2020 (EULAR 2020) virtual meeting.
Canakinumab was previously approved for the treatment of Systemic Juvenile Idiopathic Arthritis.
June 16, 2020
Dr. Richard Furie explains the link between systemic lupus erthematosus and COVID-19.
June 11, 2020
Dr. Vibeke Strand discusses the relationship between COVID-19 and psoriatic arthritis.
Dr. Vibeke Strand discusses how better treatment of psoriatic arthritis could yield better treatments for NASH.
Gout must be treated every day rather than as a single event.
June 10, 2020
John Botson, MD, defines gout and how it can be treated.
June 09, 2020
A clinical rheumatologist breaks down how the combination therapy can be used to treat uncontrolled gout.
The drug is well-tolerated in methotrexate inadequate response patients with rheumatoid arthritis.